HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Guerlain Reformulated Issima Skincare Soothes With Calmitine-S Complex

This article was originally published in The Rose Sheet

Executive Summary

Guerlain's 20-year-old anti-aging Issima Skincare line is being updated to showcase an exclusive floral-based ingredient complex - Calmitine-S - that soothes sensitive or irritated skin, the LVMH firm said.

You may also be interested in...



Issima Substantific Skin Care Line Addresses Menopausal Changes

Guerlain is targeting menopausal changes in skin with the introduction of a new facial treatment line called Substantific. The three-SKU line will debut in October under the Parisian firm's high-end Issima brand.

Issima Substantific Skin Care Line Addresses Menopausal Changes

Guerlain is targeting menopausal changes in skin with the introduction of a new facial treatment line called Substantific. The three-SKU line will debut in October under the Parisian firm's high-end Issima brand.

Guerlain Mahora Fragrance Blossoms Under $2 Mil.-$3 Mil. Ad Campaign

Perfumer Jean-Paul Guerlain's latest and most modern fragrance, Mahora, will bow stateside in April backed by a $2 mil.-$3 mil. ad spend, the LVMH company said at a press event in New York City Nov. 15.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009082

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel